Indian cancer centres adopting patient-reported outcomes to assess benefit-risk profile of therapies: Nandita Vijayasimha, Bengaluru Monday, November 18, 2024, 08:00 Hrs [IST] Ind ...
A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...
The Medical Physics in Cancer Radiation Therapy MSc is a one-year full-time (two-year part-time) programme at the University of Manchester. Applications are now open for the next academic year, and it ...
Nipocalimab was granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease based on results from the Phase 2 DAHLIAS study ...